射频消融联合低频超声辐射微泡治疗肝癌的临床研究

Radiofrequency ablation combined with low frequency ultrasound radiation with microbubble for the treatment of malignant liver neoplasms

  • 摘要: 目的 探讨RFA联合低频超声辐射微泡治疗肝癌的临床疗效。
    方法 回顾性分析2010年1月至2011年6月成都军区昆明总医院收治的25例行RFA联合低频超声辐射微泡治疗的肝癌患者的临床资料。患者在超声引导下行肝癌RFA治疗,RFA术后1周根据超声造影结果规划的治疗靶点行低频超声辐射治疗。患者术前、术后3个月、术后6个月行超声造影检查,并检测肝功能和血AFP水平。计量资料的比较采用配对t检验,计数资料采用χ2检验。
    结果 25例患者治疗后3个月,16例肿瘤缩小,平均体积较治疗前缩小30%;治疗后6个月,17例肿瘤缩小,平均体积较治疗前缩小50%;7例肿瘤有所缩小,但周边存留血流信号;1例肿瘤无缩小。25例患者AST、TBil、AFP治疗后3个月较治疗前降低,差异有统计学意义(t=23.51,13.79,257.07,P<0.05);治疗后6个月ALT、AST、TBil、AFP均比治疗前下降,差异有统计学意义(t=5.67,27.19,21.02,333.46,P<0.05)。随访6个月患者均无肿瘤局部复发,生命质量评分:84.0%(21/25)的患者良好,8.0%(2/25)较好,4.0%(1/25)一般,4.0%(1/25)较差。KPS评分:76.0%(19/25)的患者体力状况改善,20.0%(5/25)稳定,4.0%(1/25)下降。两种评分与治疗前比较,差异均有统计学意义(χ2=41.600,18.960,P<0.05)。
    结论 RFA联合低频超声辐射微泡治疗肝脏恶性肿瘤,可以缩小肿瘤体积,保护肝功能,治疗效果安全有效。

     

    Abstract: Objective To investigate the clinical efficacy and safety of radiofrequency ablation (RFA) combined with low frequency ultrasound radiation with microbubble for the treatment of malignant liver neoplasms.
    Methods The clinical data of 25 patients with malignant liver neoplasms who received RFA combined with low frequency ultrasound radiation with microbubble at the Kunming General Hospital from January 2010 to June 2011 were retrospectively analyzed. RFA was firstly performed with ultrasonic guidance, and then low frequency ultrasound radiation with microbubble was performed according to the results of ultrasound contrast examination 1 week after RFA. Ultrasound contrast examination was performed and the hepatic function and serum alpha fetoprotein (AFP) were assayed before operation, 3 and 6 months after operation, respectively. All data were analyzed using the  t test or chisquare test.
    Results The gross tumor volumes of 16 patients reduced by 30% at 3 months after operation when compared with that before operation. The gross tumor volumes of 17 patients reduced by 50% at 6 months after operation when compared with that before operation. The gross tumor volume of 7 patients reduced, but tissues surrounding tumors showed the signal of bloodstream. The gross tumor volume of 1 patient did not reduce.The levels of aspartate aminotransferase (AST), total bilirubin (TBil) and alpha fetoprotein (AFP) at 3 months after operation were significantly lower than those before operation (t=23.51, 13.79, 257.07, P<0.05).The levels of alanine aminotransferase (ALT), AST, TBil and AFP at 6 months after operation were significantly  lower than those before operation (t=5.67, 27.19, 21.02, 333.46, P<0.05). No local recurrence was detected during a follow up of 6 months. The scores of quality of life (QOL) were very good in 21 (84.0%) patients, good in 2 (8.0%) patients, fair in 1 (4.0%) patient and poor in 1 (4.0%) patient. The scores of Karnofsky (KPS) were improved in 19 (76.0%) patients, stable in 5 (20.0%) patients and aggravated in 1 (4.0%) patient. There were significant differences in QOL and KPS between preand postoperation (χ2=41.600, 18.960, P<0.05).
    Conclusion RFA combined with low frequency ultrasound radiation with microbubble is effective in reducing the tumor size and protect the hepatic function for patients with malignant liver neoplasms.

     

/

返回文章
返回